Basilea reports activity of derazantinib in preclinical models of gastric cancer at ASCO Gastrointestinal Cancers Symposium

NEXT STORY
Marketing authorization granted for darolutamide in Japan
PREV STORY
Roche’s Risdiplam meets primary endpoint in pivotal FIREFISH trial in infants with type 1 spinal muscular atrophy
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CareDx Presents Donor-Derived Cell-Free DNA Data at the Association for Molecular Pathology and American Society of Nephrology Annual Meetings

BRISBANE, Calif., Nov. 9, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics ...

author_avatar
NASDAQ Market News

American BriVision Reports Completion of ABV-1505 Phase II Part I Clinical Trial for Treatment of Adult ADHD

author_avatar
NASDAQ Market News

Verona Pharma plc Operational Update and Financial Results for the Three and Six Months Ended June 30, 2020

author_avatar
NASDAQ Market News